Wingate Wealth Advisors’s Foghorn Therapeutics FHTX Stock Holding History

Wingate Wealth Advisors’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,471	Closed	-$104K	–	102
2025 Q1	$104K	Hold	28,471	–	–	0.12%	92
2024 Q4	$134K	Buy	+28,471	New	+$207K	0.13%	120

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Wingate Wealth Advisors's FHTX Position: Q2 2025 in Review

Wingate Wealth Advisors sold out of Foghorn Therapeutics (FHTX) in Q2 2025, closing a stake of 28,471 shares — an estimated $104K sold.

Wingate Wealth Advisors first reported a position in FHTX in Q4 2024 and held it in 2 quarters. The position peaked at $134K in Q4 2024. 81 funds tracked by Wall St. Rank hold FHTX as of Q2 2025.

Wingate Wealth Advisors reported no remaining Foghorn Therapeutics position as of Q2 2025 after selling out during the quarter.
Wingate Wealth Advisors sold 28,471 Foghorn Therapeutics shares in Q2 2025, an estimated $104K.
Wingate Wealth Advisors first reported a position in Foghorn Therapeutics in Q4 2024 and held it in 2 quarters.
Wingate Wealth Advisors's Foghorn Therapeutics position peaked at $134K in Q4 2024.
81 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2025.

Based on Wingate Wealth Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.